Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias

Revista Espanola de Enfermedades Digestivas

Volumn 104, Issue 2, 2012, Pages 69-71

  Garrido, Antonio ^a   Sayago, Manuel ^a   López, Jaime ^a   León, Rafael ^a   Bellido, Francisco ^a   Márquez, Jose Luis ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Angiodysplasia; Gastrointestinal bleeding; Thalidomide; Vascular malformations

Indexed keywords

HEMOGLOBIN; OCTREOTIDE; THALIDOMIDE;

AGED; ANGIODYSPLASIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL ANGIODYSPLASIA; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN DETERMINATION; HUMAN; MALE; PROSPECTIVE STUDY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 84857726440     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082012000200005     Document Type: Article

References (11)

1. Ge ZZ, Chen HM, Gao YJ, Liu WZ, Xu CH, Tan HH et al. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformations. Gastroenterology 2011;141:1629-37.
2. Kamalaporn P, Saravanan R, Cirocco M, May G, Kortau P, Candel G. Tha-lidomide for the treatment of chronic gastrointestinal bleeding from angio-dysplasias: a case series. Eur J Gastroenterol Hepatol 2009;21:1347-50.
3. Craanen ME, van Triest B, Verjeihen RH, Mulder CJ. Thalidomide in refractory haemorrhagic radiation induced proctitis. Gut 2006;55:1371-2.
4. Hanje A, Shamp JL, Thomas FB, Meis GM. Thalidomide-induced severe hepatotoxicity. Pharmacotherapy 2006;26:1018-22.
5. Bauditz J, Lochs H, Voderholzer W. Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide. Endoscopy 2006;38:1036-9.
6. Serralta D, Arjona I, García A, Sanz M, Turégano F. Hemorragia invalidante y recidivante por angiodisplasia intestinal: tratamiento con talidomida. Rev Esp Enferm Dig 2008;100:306-7.
7. Fernández LI, Velayos B, Fernández I, Aller R, González JM. Eficacia de la talidomida en la hemorragia digestiva por angiodisplasias. Rev Esp Enferm Dig 2009:101:371.
8. Karajeh MA, Hursltone DP, Stephenson TJ, Ray-Chaudhuri D, Gleeson DC. Refractory bleeding from portal hypertensive gastropathy: A further novel role for thalidomide therapy? Eur J Gastroenterol Hepatol 2006;18:545-8.
9. Hirri HM, Green PJ, Lindsay J. Von Willebrand's disease and angiodysplasia treated with thalidomide. Haemophilia 2006;12:285-6.
10. Molina-Infante J, Pérez-Gallardo B. Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed? Dig Dis Sci 2011;56:266-7.
11. Molina-Infante J, Pérez-Gallardo B, Fernández-Bermejo M. Avances en el tratamiento farmacológico de la hemorragia digestiva de origen oscuro. Rev Esp Enferm Dig 2007;99:457-62.